Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Return on Invested Capital (2016 - 2018)

Historic Return on Invested Capital for China Pharma Holdings (CPHI) over the last 10 years, with Q4 2018 value amounting to 0.29%.

  • China Pharma Holdings' Return on Invested Capital rose 800.0% to 0.29% in Q4 2018 from the same period last year, while for Dec 2018 it was 0.29%, marking a year-over-year increase of 800.0%. This contributed to the annual value of 0.27% for FY2018, which is 900.0% up from last year.
  • According to the latest figures from Q4 2018, China Pharma Holdings' Return on Invested Capital is 0.29%, which was up 800.0% from 0.41% recorded in Q3 2018.
  • In the past 5 years, China Pharma Holdings' Return on Invested Capital ranged from a high of 0.07% in Q4 2015 and a low of 0.44% during Q1 2015
  • Moreover, its 5-year median value for Return on Invested Capital was 0.25% (2015), whereas its average is 0.25%.
  • The largest annual percentage gain for China Pharma Holdings' Return on Invested Capital in the last 5 years was 3000bps (2015), contrasted with its biggest fall of -3100bps (2015).
  • Over the past 5 years, China Pharma Holdings' Return on Invested Capital (Quarter) stood at 0.37% in 2014, then surged by 82bps to 0.07% in 2015, then plummeted by -103bps to 0.13% in 2016, then plummeted by -175bps to 0.37% in 2017, then rose by 21bps to 0.29% in 2018.
  • Its last three reported values are 0.29% in Q4 2018, 0.41% for Q3 2018, and 0.38% during Q2 2018.